Assessment of tenascin-C levels in ventricular noncompaction/ hypertrabeculation patients: A cross-sectional study

Echocardiography

Volumn 31, Issue 2, 2014, Pages 203-208

  Erer, Hatice Betul ^a   Guvenc, Tolga Sinan ^b   Kemik, Ahu Sarbay ^c   Yilmaz, Hale ^a   Kul, Seref ^d   Altay, Servet ^a   Oz, Dilaver ^a   Zeren, Gonul ^a   Ekmekci, Ahmet ^a   Zencirci, Aycan Esen ^a   Sayar, Nurten ^a   Eren, Mehmet ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Cardiomyopathy; Hypertrabeculation; Noncompaction; Tenascin C

Indexed keywords

BIOLOGICAL MARKER; TENASCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART EJECTION FRACTION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; VENTRICULAR NONCOMPACTION HYPERTRABECULATION;

CARDIOMYOPATHY; HYPERTRABECULATION; NONCOMPACTION; TENASCIN-C;

ADULT; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CROSS-SECTIONAL STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TENASCIN; ULTRASONOGRAPHY;

EID: 84897067279     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12328     Document Type: Article

References (24)

1. Engberding R, Bender F: Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography: Persistence of isolated myocardial sinusoids. Am J Cardiol 1984;53:1733-1734.
2. Engberding R, Stöllberger C, Ong P, et al: Isolated Non-Compaction Cardiomyopathy. Dtsch Arztebl Int 2010;107:206-213.
3. Engberding R, Yelbuz MT, Breithardt G: Isolated noncompaction of the left ventricular myocardium. A review of the literature two decades after the initial case description. Clin Res Cardiol 2007;96:481-488.
4. Nagavalli S, Vacek JL: Approach to incidentally diagnosed isolated ventricular noncompaction of myocardium. South Med J 2010;103:662-668.
5. Niebroj-Dobosz I: Tenascin-C in human cardiac pathology. Clin Chim Acta 2012;413:1516-1518.
6. Imanaka-Yoshida K, Hiroe M, Yoshida T: Interaction between cell and extracellular matrix in heart disease: Multiple roles of tenascin-C in tissue remodeling. Histol Histopathol 2004;19:517-525.
7. Jenni R, Oechslin EN, van der Loo B: Isolated ventricular noncompaction of the myocardium in adults. Heart 2007;93:11-15.
8. Stöllberger C, Finsterer J, Blazek G: Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002;90:899-902.
9. Harvey RP: Patterning the vertebrate heart. Nat Rev Genet 2002;7:544-556.
10. Srivastava D, Olson EN: A genetic blueprint for cardiac development. Nature 2000;407:221-226.
11. Freedom RM, Yoo SJ, Perrin D, et al: The morphological spectrum of ventricular noncompaction. Cardiol Young 2005;15:345-364.
12. Weiford BC, Subbarao VD, Mulhern KM: Noncompaction of the ventricular myocardium. Circulation 2004;109: 2965-2971.
13. Hofer M, Stollberger C, Finsterer J: Acquired noncompaction associated with myopathy. Int J Cardiol 2007;121:296-297.
14. Linask KK, Gui YH: Inhibitory effects of ouabain on early heart development and cardiomyogenesis in the chick embryo. Dev Dyn 1995;203:93-105.
15. Linask KK, Knudsen KA, Gui YH: N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. Dev Biol 1997;185:148-164.
16. Imanaka-Yoshida K, Matsumoto K, Hara M, et al: The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation 2003;71:291-298.
17. Kitaoka H, Kubo T, Baba Y, et al: Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy. J Cardiol 2012;59:209-214.
18. Sato Y, Matsumoto N, Matsuo S, et al: Myocardial perfusion abnormality and necrosis in a patient with isolated noncompaction of the ventricular myocardium: Evaluation by myocardial perfusion SPECT and magnetic resonance imaging. Int J Cardiol 2007;120:e24-e26.
19. Soler R, Rodriguez E, Monserrat L, et al: MRI of subendocardial perfusion deficits in isolated left ventricular noncompaction. J Comput Assist Tomogr 2002;26: 373-375.
20. Kohli SK, Pantazis AA, Shah JS, et al: Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: Time for a reappraisal of diagnostic criteria? Eur Heart J 2008;29:89-95.
21. Jacquier A, Thuny F, Jop B, et al: Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular noncompaction. Eur Heart J 2010;31:1098-1104.
22. Fern-Andez-Golfõn C, Pach-on M, Corros C, et al: Left ventricular trabeculae: Quantification in different cardiac diseases and impact on left ventricular morphological and functional parameters assessed with cardiac magnetic resonance. J Cardiovasc Med (Hagerstown) 2009;10: 827-833.
23. Germans T, Wilde AA, Dijkmans PA, et al: Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48:2518-2523.
24. Johansson B, Maceira AM, Babu-Narayan SV, et al: Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol 2007;50:1294-1295.